Skip to main content

Advertisement

Table 5 Characteristics of sarcoidosis patients

From: A national internet-linked based database for pediatric interstitial lung diseases: the French network

Patient number Sex Age at diagnosis (years) Follow up (years) BAL lymphocytes (%) Organs involved (biopsied organ)
1* M 6.5 9.4 42 Lung, lymphadenopathy
2 M 8.0 3.6 48 Lung, lymphadenopathy, eye (uveitis)
3 F 13.8 2 64 Lung, liver
4 M 13.5 3.8 69 Lung, lymphadenopathy, liver
5 M 12.7 4.2 28 Lung, lymphadenopathy
6 F 8.2 2.7 49 Lung, lymphadenopathy, bone marrow, spleen
7 F 7.1 2.4 30 Lung, lymphadenopathy, bowel
8 F 11.2 4 MD Lung, skin
9 M 14.4 3.1 20 Lung, lymphadenopathy, parotid, eye, joints
10 M 5.9 6.7 29 Lung, skin, spleen
11* F 9.1 9.1 59 Lung, lymphadenopathy, liver, eye
12 F 13 3.3 MD Lung, eye, liver, kidney, skin
13 F 11.5 2.6 72 Lung, joints, lymphadenopathy
14 F 10.8 2 12 Lung
15 M 12.8 2.5 18 Lung, liver, skin, eye, bone marrow
16 M 5.6 5.2 MD Lung, larynx, tonsils
17 F 14 4 MD Lung, joints, eye
18 F 9.6 0.8 23 Lung, liver, lymphadenopathy
19 F 8.3 0.4 MD Lung
20 M 9 9.2 50 Lung
21 M 9.3 MD MD Lung, lymphadenopathy, central nervous system
Total Sex ratio 1 Median 9.4 Median
3.4
  Restricted to the lung = 3, multi-organic = 18
  1. * Published patients.
  2. Abbreviations: M: male. F: female. MD: missing data. BAL: broncho-alveolar lavage.